Clinical Trial Update: A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of TQB3455 tablets for hematological malignancies is currently recruiting in patients with acute myeloid leukemia and myelodysplastic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• TQB3455 Tablets

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 1 | Status: RECRUITING